Home Newsfeeds Alembic Global Downgrades Albany Intl to Neutral

Alembic Global Downgrades Albany Intl to Neutral

Alembic Global analyst Peter Skibitski downgrades Albany Intl (NYSE:AIN) from Overweight to Neutral.

byBenzinga Newsdesk

August 16, 2022

1 minute read

Alembic Global analyst Peter Skibitski downgrades Albany Intl (NYSE:AIN) from Overweight to Neutral.

MDU Resources Reaffirmed FY22 Adj. EPS Outlook of $1.75 – $1.90, Vs. $2.01 Estimate

By Benzinga Newsdesk

November 3, 8:07 AM

Guidance MDU Resources affirmed it expects adjusted earnings per share in the range of $1.75 to $1.90 in 2022, based on these assumptions: Normal weather for the remainder of 2022, including precipitation and

MDU

DA Davidson Maintains Buy on Coinbase Global, Lowers Price Target to $70

By Benzinga Newsdesk

November 16, 9:54 AM

DA Davidson analyst Christopher Brendler maintains Coinbase Global (NASDAQ:COIN) with a Buy and lowers the price target from $100 to $70.

COIN

RBC Capital Maintains Outperform on CrowdStrike Holdings, Lowers Price Target to $200

By Benzinga Newsdesk

November 28, 8:42 AM

RBC Capital analyst Matthew Hedberg maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Outperform and lowers the price target from $236 to $200.

CRWD

Arconic, Rhythm Pharmaceuticals And Some Other Big Stocks Moving Lower In Today’s Pre-Market Session

By Lisa Levin

September 15, 6:23 AM

U.S. stock futures traded higher this morning ahead of several economic reports. Here are some big stocks recording losses in today’s pre-market trading session.

ARNC

Alembic Global Downgrades Albany Intl to Neutral

Related Posts

MDU Resources Reaffirmed FY22 Adj. EPS Outlook of $1.75 – $1.90, Vs. $2.01 Estimate

DA Davidson Maintains Buy on Coinbase Global, Lowers Price Target to $70

RBC Capital Maintains Outperform on CrowdStrike Holdings, Lowers Price Target to $200

Arconic, Rhythm Pharmaceuticals And Some Other Big Stocks Moving Lower In Today’s Pre-Market Session